共 50 条
- [41] Novel multi-parametric SUV/Patlak FDG-PET whole-body imaging framework for routine application to clinical oncologyJOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)Karakatsanis, NicolasLodge, MartinZhou, YunCasey, MichaelWahl, RichardSubramaniam, RathanZaidi, HabibRahmim, Arman
- [42] Using a novel PSMA-PET and PSA-based model to enhance the diagnostic accuracy for clinically significant prostate cancer and avoid unnecessary biopsy in men with PI-RADS ≤ 3 MRIEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, 52 (03) : 913 - 924Li, YujiaLi, JianYang, JinhuiXiao, LingZhou, MingCai, YiRominger, AxelShi, KuangyuSeifert, RobertGao, XiaomeiTang, YongxiangHu, Shuo
- [43] Novel AI-Based Solution for Supporting Prostate Cancer Diagnosis Increases the Efficiency and Accuracy of Reporting in Clinical RoutineLABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 598 - 599Raoux, DelphineYazbin, IssarArbov, ShayDecktor, GevRossat, StephaneRouleau, VincentTingaud, ClaireBoissy, ChristianCarpentier, SeverineNeumann, FredericTerrier, Jean-PierreVecsler, MonuelaLaifenfeld, DaphnaLinhart, Chaim
- [44] Novel AI-Based Solution for Supporting Prostate Cancer Diagnosis Increases the Efficiency and Accuracy of Reporting in Clinical RoutineMODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 598 - 599Raoux, DelphineYazbin, IssarArbov, ShayDecktor, GevRossat, StephaneRouleau, VincentTingaud, ClaireBoissy, ChristianCarpentier, SeverineNeumann, FredericTerrier, Jean-PierreVecsler, ManuelaLaifenfeld, DaphnaLinhart, Chaim
- [45] First clinical application of the novel PSMA-11-derived hybrid molecule PSMA-914 for preoperative PET/CT imaging and fluorescence-guided surgery of prostate cancerEUROPEAN UROLOGY, 2022, 81 : S990 - S990Jilg, C. A.Eder, A. C.Omrane, M. A.Stadlbauer, S.Roscher, M.Khoder, W. Y.Gratzke, C.Kopka, K.Meyer, P. T.Ruf, J.
- [46] PSMA-targeted [18F]DCFPyL PET/CT-avid lesions in a patient with prostate cancer: Clinical decision-making informed by the PSMA-RADS interpretive frameworkUROLOGY CASE REPORTS, 2019, 23 : 72 - 74Reyes, Diane K.Demehri, ShadpourWerner, Rudolf A.Pomper, Martin G.Gorin, Michael A.Rowe, Steven P.Pienta, Kenneth J.
- [47] Exploiting biospectroscopy as a novel screening tool for cervical cancer: towards a framework to validate its accuracy in a routine clinical settingBIOANALYSIS, 2013, 5 (21) : 2697 - 2711Purandare, Nikhil C.Trevisan, JulioPatel, Imran I.Gajjar, KetanMitchell, Alana L.Theophilou, GeorgiosValasoulis, GeorgeMartin, Maryvon Buenau, GuentherKyrgiou, MariaParaskevaidis, EvangelosMartin-Hirsch, Pierre L.Prendiville, Walter J.Martin, Francis L.
- [49] CAN WE RELY ON AVAILABLE MODELS TO IDENTIFY CANDIDATES FOR EXTENDED PELVIC LYMPH NODE DISSECTION (EPLND) IN MEN STAGED WITH PSMA-PET? EXTERNAL VALIDATION OF THE BRIGANTI NOMOGRAMS AND DEVELOPMENT OF A NOVEL TOOL TO IDENTIFY OPTIMAL CANDIDATES FOR EPLNDJOURNAL OF UROLOGY, 2023, 209 : E328 - E329Gandaglia, GiorgioRobesti, DanieleBrunocilla, EugenioDal Moro, FabrizioMoreno-Sierra, JesusMattei, AgostinoAfferi, LucaShariat, ShahrokDarr, ChristopherFendler, WolfgangMarra, GiancarloGontero, PaoloZhuang, JunlongGuo, HongqianSchiavina, RiccardoBianchi, LorenzoZattoni, FabioRajwa, PawelGomez-Rivas, JuanKesch, ClaudiaPorpiglia, FrancescoAmparore, DanielePicchio, MariaMontorsi, FrancescoBriganti, Alberto
- [50] Can we rely on available models to identify candidates for extended Pelvic Lymph Node Dissection (ePLND) in men staged with PSMA-PET? External validation of the Briganti nomograms and development of a novel tool to identify optimal candidates for ePLNDEUROPEAN UROLOGY, 2023, 83 : S923 - S924Gandaglia, G.Robesti, D.Bianchi, L.Schiavina, R.Brunocilla, E.Afferi, L.Mattei, A.Zattoni, F.Rajwa, P.Shariat, S.Kesch, C.Sierra, J. M.Gontero, P.Marra, G.Guo, H.Rivas, Gomez J.Zhuang, J.Amparore, D.Dal Moro, F.Porpiglia, F.Darr, C.Fendler, W.Picchio, M.Montorsi, F.Briganti, A.